Advances in the molecular mechanisms underlying progestin resistance in endometrial cancerOACSCD
Advances in the molecular mechanisms underlying progestin resistance in endometrial cancer
Jie Liu;Jingyi Zhou;Yiqin Wang;Fengxia Xue;Xiaojun Chen;Gang Chen;Jianliu Wang
Department of Obstetrics and Gynecology,Peking University People's Hospital,Beijing 100044,ChinaDepartment of Obstetrics and Gynecology,Peking University People's Hospital,Beijing 100044,ChinaDepartment of Obstetrics and Gynecology,Peking University People's Hospital,Beijing 100044,ChinaDepartment of Obstetrics and Gynecology,Tianjin Medical University General Hospital,Tianjin 300052,ChinaDepartment of Gynecology,Obstetrics and Gynecology Hospital,Fudan University,Shanghai 200011,ChinaDeparment of Gynecology and Obstetrics,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,ChinaDepartment of Obstetrics and Gynecology,Peking University People's Hospital,Beijing 100044,China
Endometrial cancerProgestin treatmentClinical efficacyMolecular mechanismsProgesterone receptorMetabolic disordersResearch model
Endometrial cancerProgestin treatmentClinical efficacyMolecular mechanismsProgesterone receptorMetabolic disordersResearch model
《自然科学基础研究(英文)》 2025 (5)
2330-2342,13
This work was supported by the National Key Technology Re-search and Developmental Program of China(2022YFC2704400 and 2022YFC2704402)and National Natural Science Foundation Key Pro-gram(82230050).
评论